EMA Issues Positive Opinion on the Safety of Filgotinib ...Middle East

Medscape - News
The EMA has issued a positive opinion of the type II variation application of the JAK1 inhibitor filgotinib, based on testicular function safety data from two phase 2 clinical trials. International Approvals

Hence then, the article about ema issues positive opinion on the safety of filgotinib was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EMA Issues Positive Opinion on the Safety of Filgotinib )

Apple Storegoogle play

Last updated :

Also on site :